Osaic Holdings
NKTR icon

Osaic Holdings’s Nektar Therapeutics NKTR Stock Holding History

Osaic Holdings’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$292K Sell
4,183
-210
-5% -$15.4K ﹤0.01% 4109
2026
Q1 		$316K Sell
4,393
-995
-18% -$56.7K ﹤0.01% 3779
2025
Q4 		$228K Sell
5,388
-38
-0.7% -$2.13K ﹤0.01% 4036
2025
Q3 		$282K Buy
5,426
+38
+0.7% +$1.26K ﹤0.01% 3927
2025
Q2 		$139K Sell
5,388
-33
-0.6% -$371 ﹤0.01% 4236
2025
Q1 		$55.3K Buy
5,421
+2,683
+98% +$35.1K ﹤0.01% 4640
2024
Q4 		$38.2K Sell
2,738
-66
-2% -$1.16K ﹤0.01% 4895
2024
Q3 		$54.7K Buy
2,804
+222
+9% +$4.23K ﹤0.01% 4675
2024
Q2 		$48K Sell
2,582
-587
-19% -$12.4K ﹤0.01% 4710
2024
Q1 		$44.3K Buy
3,169
+917
+41% +$9.6K ﹤0.01% 4833
2023
Q4 		$19.1K Sell
2,252
-711
-24% -$5.38K ﹤0.01% 5519
2023
Q3 		$26.5K Sell
2,963
-201
-6% -$1.94K ﹤0.01% 5398
2023
Q2 		$27.2K Buy
3,164
+266
+9% +$2.84K ﹤0.01% 5358
2023
Q1 		$31.1K Buy
2,898
+143
+5% +$4.33K ﹤0.01% 5294
2022
Q4 		$92.5K Sell
2,755
-296
-10% -$14.3K ﹤0.01% 4502
2022
Q3 		$147K Buy
3,051
+13
+0.4% +$773 ﹤0.01% 4031
2022
Q2 		$174K Sell
3,038
-59
-2% -$3.72K ﹤0.01% 3931
2022
Q1 		$3.46M Buy
3,097
+871
+39% +$129K 0.01% 1477
2021
Q4 		$452K Buy
2,226
+380
+21% +$82.4K ﹤0.01% 3164
2021
Q3 		$498K Sell
1,846
-885
-32% -$213K ﹤0.01% 3035
2021
Q2 		$702K Buy
2,731
+460
+20% +$127K ﹤0.01% 2666
2021
Q1 		$681K Sell
2,271
-125
-5% -$38.9K ﹤0.01% 2560
2020
Q4 		$611K Sell
2,396
-185
-7% -$47.8K ﹤0.01% 2460
2020
Q3 		$645K Buy
2,581
+269
+12% +$84.6K ﹤0.01% 2202
2020
Q2 		$803K Sell
2,312
-768
-25% -$240K ﹤0.01% 1921
2020
Q1 		$809K Buy
+3,080
New +$953K ﹤0.01% 1693

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Osaic Holdings's NKTR Position: Q2 2026 in Review

Osaic Holdings reduced its Nektar Therapeutics (NKTR) stake by 4.8% in Q2 2026, selling an estimated $15.4K and leaving 4,183 shares worth $292K. The position accounts for ﹤0.01% of the portfolio, ranked #4109.

Osaic Holdings first reported a position in NKTR in Q1 2020 and has held it in 26 quarters since. The position peaked at $3.46M in Q1 2022. 239 funds tracked by Wall St. Rank hold NKTR as of Q2 2026.

  • Osaic Holdings held 4,183 shares of Nektar Therapeutics worth $292K as of Q2 2026.
  • Osaic Holdings sold 210 Nektar Therapeutics shares in Q2 2026, an estimated $15.4K.
  • Nektar Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #4109 holding.
  • Osaic Holdings first reported a position in Nektar Therapeutics in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Nektar Therapeutics position peaked at $3.46M in Q1 2022.
  • 239 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.